|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/41 | |
| C07D 257/04 | |||
| C07C 233/47 |
| (11) | Patento numeris | 3229799 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15843405.0 |
| Europos patento paraiškos padavimo data | 2015-12-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-10-18 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/064432 |
| Data | 2015-12-08 |
| (87) | Numeris | WO 2016/049663 |
| Data | 2016-03-31 |
| (30) | Numeris | Data | Šalis |
| 201462089225 P | 2014-12-08 | US |
| (72) |
CHEN, Minhua, US
ZHANG, Yanfeng, CN
YANG, Chaohui, CN
ZHANG, Xiaoyu, CN
LI, Jiaoyang, CN
WANG, Peng, US
LI, Pixu, CN
|
| (73) |
Crystal Pharmatech Co., Ltd.,
B4-101, Biobay, 218 Xinghu Street Suzhou Industrial Park, Suzhou, 215123,
CN
Suzhou Pengxu Pharmatech Co., Ltd., 3rd Floor, Building 7 2358 Changan Road Wujiang, Suzhou, 215200, CN |
| (54) | CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |
| CRYSTALLINE FORMS OF TRISODIUM SUPRAMOLECULAR COMPLEX COMPRISING VALSARTAN AND AHU-377 AND METHODS THEREOF |